Publication Cover
Archives of Physiology and Biochemistry
The Journal of Metabolic Diseases
Volume 128, 2022 - Issue 2
569
Views
18
CrossRef citations to date
0
Altmetric
Review Article

Inflammation, oxidative stress and altered heat shock response in type 2 diabetes: the basis for new pharmacological and non-pharmacological interventions

ORCID Icon & ORCID Icon
Pages 411-425 | Received 19 Aug 2019, Accepted 24 Oct 2019, Published online: 20 Nov 2019

References

  • Abo-Salem, O.M., et al., 2009. Experimental diabetic nephropathy can be prevented by propolis: effect on metabolic disturbances and renal oxidative parameters. Pakistan journal of pharmaceutical sciences, 22 (2), 205–210.
  • Adamis, A.P., 2002. Is diabetic retinopathy an inflammatory disease? British journal of ophthalmology, 86 (4), 363–365.
  • Afzal, S., et al., 2013. Low 25-hydroxyvitamin D and risk of type 2 diabetes: a prospective cohort study and metaanalysis. Clinical chemistry, 59 (2), 381–391.
  • Ahmadian, M., et al., 2013. PPARgamma signaling and metabolism: the good, the bad and the future. Nature medicine, 19 (5), 557–566.
  • Ahmed, O.M., et al., 2010. Antihyperglycemic, antihyperlipidemic and antioxidant effects and the probable mechanisms of action of Ruta graveolens infusion and rutin in nicotinamide-streptozotocin-induced diabetic rats. Diabetologia croatica, 39 (1), 15–35.
  • Akash, M.S.H., et al., 2018. Biochemical investigation of gender-specific association between insulin resistance and inflammatory biomarkers in types 2 diabetic patients. Biomedicine & pharmacotherapy, 106, 285–291.
  • Akerfelt, M., et al., 2010. Heat shock factors: integrators of cell stress, development and lifespan. Nature reviews molecular cell biology, 11 (8), 545–555.
  • Albers, J.W.H., et al., 2007. Subclinical neuropathy among diabetes control and complications trial participants without diagnosable neuropathy at trial completion: possible predictors of incident neuropathy? Diabetes care, 30 (10), 2613–2618.
  • Al-Enazi, M.M., 2014. Protective effects of combined therapy of Rutin with Silymarin on experimentally-induced diabetic neuropathy in rats. Pharmacology & pharmacy, 5 (9), 876.
  • Alzamil, H., et al., 2018. Physical fitness and its relationship to plasma leptin, leptin soluble receptor, and free leptin index in a Saudi population: a comparison between diabetic and non-diabetic individuals. Medical science monitor basic research, 24, 113–119.
  • Anderson, D., et al., 1998. Comet assay responses as indicators of carcinogen exposure. Mutagenesis, 13 (6), 539–555.
  • Arif, M., et al., 2010. DNA damage and plasma antioxidant indices in Bangladeshi type 2 diabetic patients. Diabetes & metabolism, 36 (1), 51–57.
  • Armstrong, D., et al., 1981. The distribution of peroxide regulating enzymes in the canine eye. Current eye research, 1 (4), 225–242.
  • Association, A.D., 2013. Executive summary: standards of medical care in diabetes 2013. Diabetes care, 36, S4eS10.
  • Association, A.D., 2016. Standards of medical care in diabetes-2016. USA. Clinical diabetes, 34, 3e5.
  • Auwerx, J., 1999. PPARgamma, the ultimate thrifty gene. Diabetologia, 42 (9), 1033–1049.
  • Babu, P.V., et al., 2013. Recent advances in understanding the anti-diabetic actions of dietary flavonoids. The journal of nutritional biochemistry, 24 (11), 1777–1789.
  • Baldissera, F.G., et al., 2018. Subacute exposure to residual oil fly ash (ROFA) increases eHSP70 content and extracellular-to-intracellular HSP70 ratio: a relation with oxidative stress markers. Cell stress chaperones, 26 (6), 1185–1192.
  • Baur, J.A., 2010. Biochemical effects of SIRT1 activators. Biochimica et biophysica acta (Bba) - proteins and proteomics, 1804 (8), 1626–1634.
  • Beckmann, R.P.L.M., and Welch, W.J., 1992. Examining the function and regulation of HSP 70 in cells subjected tometabolic stress. The journal of cell biology, 117 (6), 1137–1150.
  • Belia, S., et al., 2009. Oxidative-induced membrane damage in diabetes lymphocytes: effects on intracellular Ca (2+) homeostasis. Free radical research, 43 (2), 138–148.
  • Bellaye, P.S., et al., 2014. Heat shock proteins in fibrosis and wound healing: good or evil? Pharmacology & therapeutics, 143 (2), 119–132.
  • Bellini, S., et al., 2017. Heat shock proteins in vascular diabetic complications: review and future perspective. International journal of molecular science, 18 (12), 2709.
  • Boni-Schnetzler, M., et al., 2009. Free fatty acids induce a proinflammatory response in islets via the abundantly expressed interleukin-1 receptor I. Endocrinology, 150 (12), 5218–5229.
  • Boule, N.G., et al., 2001. Effects of exercise on glycemic control and body mass in type 2 diabetes mellitus: a meta-analysis of controlled clinical trials. JAMA, 286 (10), 1218–121227.
  • Boveris, A., et al., 1972. [The function of liver mitochondria after steroid administration]. Revista de la sociedad argentina de biologia, 48–49 (1–8), 73–83.
  • Brinkmann, C., et al., 2018. Endurance training alters YKL40, PERM1, and HSP70 skeletal muscle protein contents in men with type 2 diabetes mellitus. Endocrine research, 44 (1–2), 1–8.
  • Brownlee, M., 2001. Biochemistry and molecular cell biology of diabetic complications. Nature, 414 (6865), 813–820.
  • Brownlee, M., 2005. The pathobiology of diabetic complications: a unifying mechanism. Diabetes, 54 (6), 1615–1625.
  • Bruschi, LKMdR., et al., 2017. Diabetes mellitus and diabetic peripheral neuropathy. Open journal of endocrine and metabolic diseases, 7 (1), 12–21.
  • Burke, S.J., et al., 2015. IL-1beta reciprocally regulates chemokine and insulin secretion in pancreatic beta-cells via NF-kappaB. American journal of physiology-endocrinology and metabolism, 309 (8), E715–726.
  • Calderwood, S.K., et al., 2016. Extracellular HSPs: the complicated roles of extracellular HSPs in immunity. Frontiers in immunology, 7, 159.
  • Callaghan, B.C., et al., 2012. Enhanced glucose control for preventing and treating diabetic neuropathy. Cochrane database of systematic review, 13 (6), CD007543.
  • Cani, P.D., et al., 2008. Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet-induced obesity and diabetes in mice. Diabetes, 57 (6), 1470–1481.
  • Castorina, C., et al., 1992. Lipid peroxidation and antioxidant enzymatic systems in rat retina as a function of age. Neurochemical research, 17 (6), 599–604.
  • Catano Canizales, Y.G., et al., 2018. Increased Levels of AIM2 and Circulating Mitochondrial DNA in Type 2 Diabetes. Iran journal of immunology, 15 (2), 142–155.
  • Chen, F., et al., 2012. Opposing actions of heat shock protein 90 and 70 regulate nicotinamide adenine dinucleotide phosphate oxidase stability and reactive oxygen species production. Arteriosclerosis, thrombosis, and vascular biology, 32 (12), 2989–2999.
  • Chen, L., et al., 2016. Thymoquinone Alleviates the Experimental Diabetic Peripheral Neuropathy by Modulation of Inflammation. Scientific reports, 6 (1), 31656.
  • Ciapaite, J., et al., 2011. Differential effects of short- and long-term high-fat diet feeding on hepatic fatty acid metabolism in rats. Biochimica et biophysica acta (Bba) - molecular and cell biology of lipids, 1811 (7-8), 441–451.
  • Colbert, L.H., et al., 2004. Physical activity, exercise, and inflammatory markers in older adults: findings from the health, aging and body composition study. Journal of the American geriatrics society, 52 (7), 1098–1104.
  • Collins, A.R., et al., 1998. DNA damage in diabetes: correlation with a clinical marker. Free radical biology and medicine, 25 (3), 373–377.
  • Creager, M.A., et al., 2003. Diabetes and vascular disease: pathophysiology, clinical consequences, and medical therapy: part I. Circulation, 108 (12), 1527–1532.
  • Dandona, P., et al., 1996. Oxidative damage to DNA in diabetes mellitus. The lancet, 347 (8999), 444–445.
  • De Vita, F., et al., 2014. Relationship between vitamin D and inflammatory markers in older individuals. Age, 36 (4), 9694.
  • Di Naso, F.C., et al., 2015. Obesity depresses the anti-inflammatory HSP70 pathway, contributing to NAFLD progression. Obesity (silver spring), 23 (1), 120–129.
  • Dimitrovska, M., et al., 2018. Physiological and pharmacological inductors of HSP70 enhance the antioxidative defense mechanisms of the liver and pancreas in diabetic rats. Canadian journal of physiology and pharmacology, 96 (2), 158–164.
  • Dobretsov, M., et al., 2007. Early diabetic neuropathy: triggers and mechanisms. World journal of gastroenterology, 13 (2), 175–191.
  • Domingueti, C.P., et al., 2016. Diabetes mellitus: the linkage between oxidative stress, inflammation, hypercoagulability and vascular complications. Journal of diabetes and its complications, 30 (4), 738–745.
  • Donath, M.Y., and Shoelson, S.E., 2011. Type 2 diabetes as an inflammatory disease. Nature reviews immunology, 11 (2), 98–107.
  • Dong, Y., et al., 2011. SIRT1 is associated with a decrease in acute insulin secretion and a sex specific increase in risk for type 2 diabetes in Pima Indians. Molecular genetics and metabolism, 104 (4), 661–665.
  • Du, S., et al., 2018. Dietary manganese and type 2 diabetes mellitus: two prospective cohort studies in China. Diabetologia, 61 (9), 1985–1995.
  • Ehses, J.A., et al., 2007. Increased number of islet-associated macrophages in type 2 diabetes. Diabetes, 56 (9), 2356–2370.
  • Eid, A.H., et al., 2016. Carvedilol alleviates testicular and spermatological damage induced by cisplatin in rats via modulation of oxidative stress and inflammation. Archives of pharmacal research, 39 (12), 1693–1702.
  • Evans, J.L., et al., 2002. Oxidative stress and stress-activated signaling pathways: a unifying hypothesis of type 2 diabetes. Endocrine reviews, 23 (5), 599–622.
  • Evans, R.M., et al., 2004. PPARs and the complex journey to obesity. Nature medicine, 10 (4), 355–361.
  • Foretz, M., et al., 2014. Metformin: from mechanisms of action to therapies. Cell metabolism, 20 (6), 953–966.
  • Frank, R.N., 2004. Diabetic retinopathy. New England journal of medicine, 350 (1), 48–58.
  • Ghosh, S., and Hayden, M.S., 2012. Celebrating 25 years of NF-kappaB research. Immunological reviews, 246 (1), 5–13.
  • Gillum, M.P., et al., 2011. Sirtuin-1 regulation of mammalian metabolism. Trends in molecular medicine, 17 (1), 8–13.
  • Gimbrone, M.A., Jr., and Garcia-Cardena, G., 2016. Endothelial cell dysfunction and the pathobiology of atherosclerosis. Circulation research, 118 (4), 620–636.
  • Goettems-Fiorin, P.B., et al., 2016. Fine particulate matter potentiates type 2 diabetes development in high-fat diet-treated mice: stress response and extracellular to intracellular HSP70 ratio analysis. Journal of physiology and biochemistry, 72 (4), 643–656.
  • Goettems-Fiorin, P.B., et al., 2019. Ovariectomy predisposes female rats to fine particulate matter exposure's effects by altering metabolic, oxidative, pro-inflammatory, and heat-shock protein levels. Environmental science and pollution research, 26 (2), 20581–20594.
  • Gomes, I.B., et al., 2015. The protective effects of oral low-dose quercetin on diabetic nephropathy in hypercholesterolemic mice. Frontiers in physiology, 6, 247.
  • Gorgens, S.W., et al., 2014. Chitinase-3-like protein 1 protects skeletal muscle from TNFalpha-induced inflammation and insulin resistance. The biochemical journal, 459 (3), 479–488.
  • Grisham, M.B., and Granger, D.N., 1989. Metabolic sources of reactive oxygen metabolites during oxidant stress and ischemia with reperfusion. Clinics in chest medicine, 10 (1), 71–81.
  • Gupta, S.K., et al., 2011. Curcumin prevents experimental diabetic retinopathy in rats through its hypoglycemic, antioxidant, and anti-inflammatory mechanisms. Journal of ocular pharmacology and therapeutics, 27 (2), 123–130.
  • Gurler, B., et al., 2000. The role of oxidative stress in diabetic retinopathy. Eye (Lond), 14 (Pt 5), 730–735.
  • Haspula, D., et al., 2019. Influence of a hyperglycemic microenvironment on a diabetic versus healthy rat vascular endothelium reveals distinguishable mechanistic and phenotypic responses. Frontiers in physiology, 10, 558.
  • Heck, T.G., et al., 2011. HSP70 expression: does it a novel fatigue signalling factor from immune system to the brain? Cell biochemistry and function, 29 (3), 215–226.
  • Heck, T.G., et al., 2017. Acute exercise boosts cell proliferation and the heat shock response in lymphocytes: correlation with cytokine production and extracellular-to-intracellular HSP70 ratio. Cell stress and chaperones, 22 (2), 271–291.
  • Hooper, P.L., et al., 2014. The importance of the cellular stress response in the pathogenesis and treatment of type 2 diabetes. Cell stress and chaperones, 19 (4), 447–464.
  • Hotamisligil, G.S., et al., 1993. Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. Science, 259 (5091), 87–91.
  • Hotamisligil, G.S., et al., 1995. Increased adipose tissue expression of tumor necrosis factor-alpha in human obesity and insulin resistance. Journal of clinical investigation, 95 (5), 2409–2415.
  • Husemoen, L.L., et al., 2012. Serum 25 (OH) D and incident type 2 diabetes: a cohort study. European journal of clinical nutrition, 66 (12), 1309–1314.
  • Iikuni, N., et al., 2008. Leptin and inflammation. Current immunology reviews, 4 (2), 70–79.
  • Iskender, H., et al., 2017. The effect of hesperidin and quercetin on oxidative stress, NF-kappaB and SIRT1 levels in a STZ-induced experimental diabetes model. Biomedicine & pharmacotherapy, 90, 500–508.
  • Ito, S., et al., 2017. A small-molecule compound inhibits a collagen-specific molecular chaperone and could represent a potential remedy for fibrosis. Journal of biological chemistry, 292 (49), 20076–20085.
  • Jadhav, R.P.G., 2012. Hypoglycemic and antidiabetic activity of flavonoids: boswellic acid, ellagic acid, quercetin, rutin on streptozotocin-nicotinamide induced type 2 diabetic rats. International journal of pharmacy and pharmaceutical sciences, 4 (2), 251–256.
  • Jimenez-Pavon, D., et al., 2012. Physical activity, fitness, and serum leptin concentrations in adolescents. The journal of pediatrics, 160 (4), 598–603. e592.
  • Jo, S.K.L.E.H., et al., 2009. Comparison of antioxidant potential and rat intestinal α-glucosidases inhibitory activities of quercetin, rutin, and isoquercetin. International journal of applied research in natural products, 2 (4), 52–60.
  • Jones, D.P., and Go, Y.M., 2010. Redox compartmentalization and cellular stress. Diabetes, obesity and metabolism, 12 (Suppl 2), 116–125.
  • Jones, Q., et al., 2011. Heat shock proteins protect against ischemia and inflammation through multiple mechanisms. Inflammation & allergy - drug targets, 10 (4), 247–259.
  • Kagan, V.E., et al., 1994. Assay of ubiquinones and ubiquinols as antioxidants. Methods in enzymology, 234, 343–354.
  • Kandimalla, R., et al., 2017. Bioactive fraction of Annona reticulata bark (or) Ziziphus jujuba root bark along with insulin attenuates painful diabetic neuropathy through inhibiting NF-kappaB inflammatory cascade. Frontiers in cellular neuroscience, 11, 73.
  • Kawasaki, K., et al., 2015. Deletion of the collagen-specific molecular chaperone Hsp47 causes endoplasmic reticulum stress-mediated apoptosis of hepatic stellate cells. Journal of biological chemistry, 290 (6), 3639–3646.
  • Kelly, B., et al., 2015. Metformin inhibits the production of reactive oxygen species from NADH: ubiquinone oxidoreductase to limit induction of interleukin-1beta (IL-1beta) and boosts interleukin-10 (IL-10) in lipopolysaccharide (LPS) -activated macrophages. Journal of biological chemistry, 290 (33), 20348–20359.
  • Kern, T.S., 2007. Contributions of inflammatory processes to the development of the early stages of diabetic retinopathy. Experimental diabetes research, 2007, 1.
  • Klok, M.D., et al., 2007. The role of leptin and ghrelin in the regulation of food intake and body weight in humans: a review. Obesity reviews, 8 (1), 21–34.
  • Knowler, W.C., et al., 2002. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. The new england journal of medicine, 346 (6), 393–403.
  • Kowaltowski, A.J., and Vercesi, A.E., 1999. Mitochondrial damage induced by conditions of oxidative stress. Free radical biology and medicine, 26 (3-4), 463–471.
  • Kowluru, R.A., and Koppolu, P., 2002. Termination of experimental galactosemia in rats, and progression of retinal metabolic abnormalities. Investigative ophthalmology & visual science, 43 (10), 3287–3291.
  • Kowluru, R.A., et al., 2001. Abnormalities of retinal metabolism in diabetes and experimental galactosemia. VII. Effect of long-term administration of antioxidants on the development of retinopathy. Diabetes, 50 (8), 1938–1942.
  • Kowluru, R.A., et al., 2003. Diabetes-induced activation of nuclear transcriptional factor in the retina, and its inhibition by antioxidants. Free radical research, 37 (11), 1169–1180.
  • Kowluru, V., and Kowluru, R.A., 2007. Increased oxidative stress in diabetes regulates activation of a small molecular weight G-protein, H-Ras, in the retina. Molecular vision, 13, 602–610.
  • Krause, M., et al., 2007. MRP1/GSX pump ATPase expression: is this the explanation for the cytoprotection of the heart against oxidative stress-induced redox imbalance in comparison to skeletal muscle cells? Cell biochemistry and function, 25 (1), 23–32.
  • Krause, M., et al., 2015. The chaperone balance hypothesis: the importance of the extracellular to intracellular HSP70 ratio to inflammation-driven type 2 diabetes, the effect of exercise, and the implications for clinical management. Mediators of inflammation, 2015, 1.
  • Kumar, A., and Mittal, R., 2017. Nrf2: a potential therapeutic target for diabetic neuropathy. Inflammopharmacology, 25 (4), 393–402.
  • Kumar, B., et al., 2013. Hesperetin rescues retinal oxidative stress, neuroinflammation and apoptosis in diabetic rats. Microvascular research, 87, 65–74.
  • Kurucz, I., et al., 2002. Decreased expression of heat shock protein 72 in skeletal muscle of patients with type 2 diabetes correlates with insulin resistance. Diabetes, 51 (4), 1102–1109.
  • Kusano, A.F.B., 2008. Total antioxidant capacity: a biomarker in biomedical and nutritional studies. Journal of cell and molecular biology, 7, 1–15.
  • La Cava, A., and Matarese, G., 2004. The weight of leptin in immunity. Nature reviews immunology, 4 (5), 371–379.
  • Laird, E., et al., 2014. Vitamin D deficiency is associated with inflammation in older Irish adults. The Journal of Clinical Endocrinology & Metabolism, 99 (5), 1807–1815.
  • LeBrasseur, N.K., et al., 2006. Thiazolidinediones can rapidly activate AMP-activated protein kinase in mammalian tissues. American journal of physiology-endocrinology and metabolism, 291 (1), E175–181.
  • Lee, S.H., et al., 2013. Manganese supplementation protects against diet-induced diabetes in wild type mice by enhancing insulin secretion. Endocrinology, 154 (3), 1029–1038.
  • Levinthal, G.N.T.A.S., 1999. Liver disease and diabetes mellitus. Clinical diabetes, 17, 245–250.
  • Ley, R.E., et al., 2005. Obesity alters gut microbial ecology. Proceedings of the national academy of sciences, 102 (31), 11070–11075.
  • Li, H., et al., 2014. Vascular oxidative stress, nitric oxide and atherosclerosis. Atherosclerosis, 237 (1), 208–219.
  • Li, Y.Q., et al., 2009. Comparative evaluation of quercetin, isoquercetin and rutin as inhibitors of α-glucosidase. Journal of agricultural and food chemistry, 57 (24), 11463–11468.
  • Liu, D., et al., 2001. The renal expression of heat shock protein 47 and collagens in acute and chronic experimental diabetes in rats. The histochemical journal, 33 (11/12), 621–628.
  • Lodovici, M., et al., 2008. Oxidative DNA damage and plasma antioxidant capacity in type 2 diabetic patients with good and poor glycaemic control. Mutation research/fundamental and molecular mechanisms of mutagenesis, 638 (1-2), 98–102.
  • Loeffler, I., and Wolf, G., 2015. Epithelial-to-mesenchymal transition in diabetic nephropathy: fact or fiction? Cells, 4 (4), 631–652.
  • Lu, C.H., et al., 2016. Additional effect of metformin and celecoxib against lipid dysregulation and adipose tissue inflammation in high-fat fed rats with insulin resistance and fatty liver. European journal of pharmacology, 789, 60–67.
  • Maedler, K., et al., 2002. Glucose-induced beta cell production of IL-1beta contributes to glucotoxicity in human pancreatic islets. Journal of clinical investigation, 110 (6), 851–860.
  • Mahmoud, A.M., et al., 2012. Hesperidin and naringin attenuate hyperglycemia-mediated oxidative stress and proinflammatory cytokine production in high fat fed/streptozotocin-induced type 2 diabetic rats. Journal of diabetes and its complications, 26 (6), 483–490.
  • Mahmoud, F.F., et al., 2018. Correlation between heat shock proteins, adiponectin, and T lymphocyte cytokine expression in type 2 diabetics. Cell stress and chaperones, 23 (5), 955–965.
  • Mai, A.S., et al., 2017. Exercise training under exposure to low levels of fine particulate matter: effects on heart oxidative stress and extra-to-intracellular HSP70 ratio. Oxidative medicine and cellular longevity, 2017, 9067875.
  • Mandosi, E., et al., 2015. Endothelial dysfunction markers as a therapeutic target for Sildenafil treatment and effects on metabolic control in type 2 diabetes. Expert opinion on therapeutic targets, 19 (12), 1617–1622.
  • Maritim, A.C., et al., 2003. Diabetes, oxidative stress, and antioxidants: a review. Journal of biochemical and molecular toxicology, 17 (1), 24–38.
  • Martinez-Gomez, D., et al., 2012. Associations of physical activity and fitness with adipocytokines in adolescents: the AFINOS Study. Nutrition, metabolism & cardiovascular disease, 22 (3), 252–259.
  • Masuzawa, K., et al., 2006. An endothelin type A receptor antagonist reverses upregulated VEGF and ICAM-1 levels in streptozotocin-induced diabetic rat retina. Current eye research, 31 (1), 79–89.
  • Mayer, M.P., and Bukau, B., 2005. Hsp70 chaperones: cellular functions and molecular mechanism. Cellular and molecular life sciences, 62 (6), 670–684.
  • Melloul, D., 2008. Role of NF-kappaB in beta-cell death. Biochemical society transactions, 36 (3), 334–339.
  • Memisogullari, R., et al., 2003. Antioxidant status and lipid peroxidation in type II diabetes mellitus. Cell biochemistry and function, 21 (3), 291–296.
  • Meza, C.A., et al., 2019. Endothelial dysfunction: is there a hyperglycemia-induced imbalance of NOX and NOS? International journal of molecular sciences, 20 (15), pii:3775.
  • Miragem, A.A., and Homem de Bittencourt, P.I., Jr., 2017. Nitric oxide-heat shock protein axis in menopausal hot flushes: neglected metabolic issues of chronic inflammatory diseases associated with deranged heat shock response. Human reproduction update, 23 (5), 600–628.
  • Mondal, L.K., et al., 2018. Biochemical scenario behind initiation of diabetic retinopathy in type 2 diabetes mellitus. Indian journal of ophthalmology, 66 (4), 535–540.
  • Moustafa, P.E., et al., 2018. Extracellular matrix remodeling and modulation of inflammation and oxidative stress by sulforaphane in experimental diabetic peripheral neuropathy. Inflammation, 41 (4), 1460–1476. doi:https://doi.org/10.1007/s10753-018-0792-9
  • Montonen, J., et al., 2004. Dietary antioxidant intake and risk of type 2 diabetes. Diabetes care, 27 (2), 362–366.
  • Muthenna, P., et al., 2012. Inhibition of advanced glycation end-product formation on eye lens protein by rutin. British journal of nutrition, 107 (7), 941–949.
  • Nagasawa, T., et al., 2003. Dietary G-rutin suppresses glycation in tissue proteins of streptozotocin-induced diabetic rats. Molecular and cellular biochemistry, 252 (1/2), 141–147.
  • Nakhjavani, M., et al., 2010. Increased serum HSP70 levels are associated with the duration of diabetes. Cell stress and chaperones, 15 (6), 959–964.
  • Nasser, Z.S., et al., 2011. Effects of melatonin in prevention of neuropathy in STZ-induced diabetic rats. American journal of pharmacology and toxicology, 6, 59–67.
  • NCCIH: National Center for Complementary and Integrative Health. Complementary or Integrative Health: What’s In a Name? (2016). NCCIH: National Center for Complementary and Integrative Health. Complementary, Alternative, or Integrative Health: What’s In a Name? Available from https://nccih.nih.gov/health/integrativehealth.
  • Ngo, D.T., et al., 2010. Does vitamin D modulate asymmetric dimethylarginine and C-reactive protein concentrations? The American journal of medicine, 123 (4), 335–341.
  • Nguyen, M.T., et al., 2007. A subpopulation of macrophages infiltrates hypertrophic adipose tissue and is activated by free fatty acids via Toll-like receptors 2 and 4 and JNK-dependent pathways. Journal of biological chemistry, 282 (48), 35279–35292.
  • Niture, N.T., et al., 2014. Anti-hyperglycemic activity of rutin in streptozotocin-induced diabetic rats: an effect mediated through cytokines, antioxidants and lipid biomarkers. Indian journal of experimental biology, 52 (7), 720–727.
  • Noble, E.G., Milne, K.J., and Melling, C.W.J., 2008. Heat shock proteins and exercise: a primer. Applied physiology, nutrition, and metabolism, 33 (5), 1050–1065.
  • Noda, K., et al., 2012. Leukocyte adhesion molecules in diabetic retinopathy. Journal of ophthalmology, 2012, 1.
  • Nogueiras, R., et al., 2012. Sirtuin 1 and sirtuin 3: physiological modulators of metabolism. physiological reviews, 92 (3), 1479–1514.
  • Oh, Y.S., 2016. Bioactive compounds and their neuroprotective effects in diabetic complications. Nutrients, 8 (8), 472–420. pii: E472.
  • Ohashi, S., et al., 2004. Advanced glycation end products increase collagen-specific chaperone protein in mouse diabetic nephropathy. Journal of biological chemistry, 279 (19), 19816–19823.
  • Oyenihi, A.B., et al., 2015. Antioxidant strategies in the management of diabetic neuropathy. BioMed research international, 2015, 1.
  • Paz-Filho, G.M., et al., 2012. Leptin: molecular mechanisms, systemic pro-inflammatory effects, and clinical implications. Arquivos brasileiros de endocrinologia & metabologia, 56 (9), 597–607.
  • Peterson, C.A., and Heffernan, M.E., 2008. Serum tumor necrosis factor-alpha concentrations are negatively correlated with serum 25 (OH) D concentrations in healthy women. Journal of inflammation, 5 (1), 10.
  • Pittaluga, M., et al., 2015. Physical exercise and redox balance in type 2 diabetics: effects of moderate training on biomarkers of oxidative stress and DNA damage evaluated through comet assay. Oxidative medicine and cellular longevity, 2015, 1.
  • Plonka, M., et al., 2011. Association of the physical activity with leptin blood serum level, body mass indices and obesity in schoolgirls. Journal of physiology and pharmacology, 62 (6), 647–656.
  • Pollack, R.M., et al., 2016. Anti-inflammatory Agents in the Treatment of Diabetes and Its Vascular Complications. Diabetes care, 39 (Supplement 2), S244–S252.
  • Ramasamy, R., et al., 2008. Receptor for advanced glycation end products: fundamental roles in the inflammatory response: winding the way to the pathogenesis of endothelial dysfunction and atherosclerosis. Annals of the New York academy of sciences, 1126 (1), 7–13.
  • Razzaque, M.S., and Taguchi, T., 1997. Collagen-binding heat shock protein (HSP) 47 expression in anti-thymocyte serum (ATS) -induced glomerulonephritis. The journal of pathology, 183 (1), 24–29.
  • Richardson, S.J., et al., 2009. Islet-associated macrophages in type 2 diabetes. Diabetologia, 52 (8), 1686–1688.
  • Richter, K., et al., 2010. The heat shock response: life on the verge of death. Molecular cell, 40 (2), 253–266.
  • Ringsholt, M., et al., 2007. YKL-40 protein expression in normal adult human tissues–an immunohistochemical study. Journal of molecular histology, 38 (1), 33–43.
  • Rodrigues-Krause, J., et al., 2012. Divergence of intracellular and extracellular HSP72 in type 2 diabetes: does fat matter? Cell stress and chaperones, 17 (3), 293–302.
  • Romeo, G., et al., 2002. Activation of nuclear factor-kB induced by diabetes and high glucose regulates a proapoptotic program in retinal pericytes. Diabetes, 51 (7), 2241–2248.
  • Rubsam, A., et al., 2018. Role of inflammation in diabetic retinopathy. International journal of molecular science, 19 (4), E942.
  • Saberi Firouzi, S., et al., 2018. Sildenafil protective effects on high glucose-induced neurotoxicity in PC12 cells: the role of oxidative stress, apoptosis, and inflammation pathways in an in vitro cellular model for diabetic neuropathy. Neurological research, 40 (8), 1–13.
  • Saghizadeh, M., et al., 1996. The expression of TNF alpha by human muscle. Relationship to insulin resistance. Journal of clinical investigation, 97 (4), 1111–1116.
  • Saisho, Y., 2015. Metformin and inflammation: its potential beyond glucose-lowering effect. Endocrine, metabolic & immune disorders-drug targets, 15 (3), 196–205.
  • Samuel, V.T., and Shulman, G.I., 2012. Mechanisms for insulin resistance: common threads and missing links. Cell, 148 (5), 852–871.
  • Santi, D., et al., 2015. Therapy of endocrine disease. Effects of chronic use of phosphodiesterase inhibitors on endothelial markers in type 2 diabetes mellitus: a meta-analysis. European journal of endocrinology, 172 (3), R103–114.
  • Scott, J.A., and King, G.L., 2004. Oxidative stress and antioxidant treatment in diabetes. Annals of the New York academy of sciences, 1031 (1), 204–213.
  • Serafini, M., and Del Rio, D., 2004. Understanding the association between dietary antioxidants, redox status and disease: is the total antioxidant capacity the right tool? Redox report, 9 (3), 145–152.
  • Sethi, J.K., and Hotamisligil, G.S., 1999. The role of TNF alpha in adipocyte metabolism. Seminars in cell & developmental biology, 10 (1), 19–29.
  • Shah, M.S., and Brownlee, M., 2016. Molecular and Cellular Mechanisms of Cardiovascular Disorders in Diabetes. Circulation research, 118 (11), 1808–1829.
  • Shaikh, A.S., and Somani, R.S., 2010. Animal models and biomarkers of neuropathy in diabetic rodents. Indian journal of pharmacology, 42 (3), 129–134.
  • Shakil-Ur-Rehman, S., et al., 2018. Response to a supervised structured aerobic exercise training program in patients with type 2 diabetes mellitus - does gender make a difference? A randomized controlled clinical trial. Journal of the national medical association, 110 (5), 431–439.
  • Shan, Z., et al., 2016. U-Shaped association between plasma manganese levels and type 2 diabetes. Environmental health perspectives, 124 (12), 1876–1881.
  • Sharma, A., et al., 2017. The nuclear factor (erythroid-derived 2) -like 2 (Nrf2) activator dh404 protects against diabetes-induced endothelial dysfunction. Cardiovascular diabetology, 16 (1), 33.
  • Shenouda, S.M., et al., 2011. Altered mitochondrial dynamics contributes to endothelial dysfunction in diabetes mellitus. Circulation, 124 (4), 444–453.
  • Shurtz-Swirski, R., et al., 2001. Involvement of peripheral polymorphonuclear leukocytes in oxidative stress and inflammation in type 2 diabetic patients. Diabetes care, 24 (1), 104–110.
  • Singh, K., et al., 2015. Decreased expression of heat shock proteins may lead to compromised wound healing in type 2 diabetes mellitus patients. Journal of diabetes and its complications, 29 (4), 578–588.
  • Soares, M., et al., 2019. Heat shock response in noise-induced hearing loss: effects of alanyl-glutamine dipeptide supplementation on heat shock proteins status. Brazilian journal of otorhinolaryngology. Available from: http://www.sciencedirect.com/science/article/pii/S1808869419300400
  • Solmaz, V., et al., 2017. Neuroprotective effects of octreotide on diabetic neuropathy in rats. Biomedicine & pharmacotherapy, 89, 468–472.
  • Srinivasan, K.K., and Ramarao, P., 2005. Partial protective effect of rutin on multiple low dose streptozotocin-induced diabetes in mice. Indian journal of pharmacology, 37 (5), 327.
  • Stolar, M.W., and Chilton, R.J., 2003. Type 2 diabetes, cardiovascular risk, and the link to insulin resistance. Clinical therapeutics, 25 (Suppl B), B4–31.
  • Sunamoto, M., et al., 1998. Antisense oligonucleotides against collagen-binding stress protein HSP47 suppress collagen accumulation in experimental glomerulonephritis. Laboratory investigations, 78 (8), 967–972.
  • Tanaka, T., et al., 1989. Changes of electron spin resonance membrane fluidity in hexadecane-induced hyperproliferative epidermis. Journal of investigative dermatology, 93 (5), 682–686.
  • Taniguchi, N., 1992. Clinical significances of superoxide dismutases: changes in aging, diabetes, ischemia, and cancer. Advances in clinical chemistry, 29, 1–59.
  • Thomas, D.E., et al., 2006. Exercise for type 2 diabetes mellitus. Cochrane database of systematic reviews, (3), CD002968. Available from: http://www.cochranelibrary.com/cdsr/doi/https://doi.org/10.1002/14651858.CD002968.pub2/full
  • Togo, M., et al., 2018. Effects of a high-fat diet on superoxide anion generation and membrane fluidity in liver mitochondria in rats. Journal of international society of sports nutrition, 15 (13), 2–8.
  • Tuomilehto, J., et al., 2001. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. New england journal of medicine, 344 (18), 1343–1350.
  • Turkmen, K., et al., 2014. Sirtuins as novel players in the pathogenesis of diabetes mellitus. World journal of diabetes, 5 (6), 894–900.
  • Vial, G., et al., 2011. Effects of a high-fat diet on energy metabolism and ROS production in rat liver. Journal of hepatology, 54 (2), 348–356.
  • Victor, V.M., et al., 2003. N-acetylcysteine protects mice from lethal endotoxemia by regulating the redox state of immune cells. Free radical research, 37 (9), 919–929.
  • Victor, V.M., et al., 2004. Immune cells: free radicals and antioxidants in sepsis. International immunopharmacology, 4 (3), 327–347.
  • Victor, V.M., et al., 2005. Role of free radicals in sepsis: antioxidant therapy. Current pharmaceutical design, 11 (24), 3141–3158.
  • Vincent, A.M., et al., 2004. Oxidative stress in the pathogenesis of diabetic neuropathy. Endocrine reviews, 25 (4), 612–628.
  • Vincent, A.M., et al., 2011. Diabetic neuropathy: cellular mechanisms as therapeutic targets. Nature reviews neurology, 7 (10), 573–583.
  • Wajchenberg, B.L., 2007. beta-cell failure in diabetes and preservation by clinical treatment. Endocrine reviews, 28 (2), 187–218.
  • Wang, Y.B., et al., 2015. Rutin alleviates diabetic cardiomyopathy in a rat model of type 2 diabetes. Experimental and therapeutic medicine, 9 (2), 451–455.
  • Wang, Z., and Li, L., 2009. The plasmid encoding HSP47 enhances collagen expression and promotes skin wound healing in an alloxan-induced diabetic model. Cell biology international, 33 (7), 705–710.
  • Wauters, M., et al., 2000. Human leptin: from an adipocyte hormone to an endocrine mediator. European journal of endocrinology, 143 (3), 293–311.
  • Wellen, K.E., and Hotamisligil, G.S., 2005. Inflammation, stress, and diabetes. Journal of clinical investigation, 115 (5), 1111–1119.
  • Xia, Z., et al., 2008. Suppression of renal tubulointerstitial fibrosis by small interfering RNA targeting heat shock protein 47. American journal of nephrology, 28 (1), 34–46.
  • Xiao, H.B., et al., 2012. HSP47 regulates ECM accumulation in renal proximal tubular cells induced by TGF-beta1 through ERK1/2 and JNK MAPK pathways. American journal of physiology-renal physiology, 303 (5), F757–765.
  • Xie, K., et al., 2018. A multi-method evaluation of the effects of Inflammatory cytokines (IL-1beta, IFN-gamma, TNF-alpha) on pancreatic beta-cells. Journal of cellular physiology, 233 (12), 9375–9382.
  • Xu, P., et al., 2017. DBZ is a putative PPARgamma agonist that prevents high fat diet-induced obesity, insulin resistance and gut dysbiosis. Biochimica et biophysica acta (BBA) - general subjects, 1861 (11), 2690–2701.
  • Yagihashi, S., Mizukami, H., and Sugimoto, K., 2011. Mechanism of diabetic neuropathy: where are we now and where to go? Journal of diabetes investigation, 2 (1), 18–32.
  • Ye, J., 2009. Emerging role of adipose tissue hypoxia in obesity and insulin resistance. International journal of obesity, 33 (1), 54–66.
  • Yu, Y., et al., 2018. Effect of vitamin D supplementation on some inflammatory biomarkers in type 2 diabetes mellitus subjects: a systematic review and meta-analysis of randomized controlled trials. Annals of nutrition and metabolism, 73 (1), 62–73.
  • Zanetti, M., et al., 2014. Ability of vitamin D to reduce inflammation in adults without acute illness. Nutrition reviews, 72 (2), 95–98.
  • Zernecke, A., and Weber, C., 2010. Chemokines in the vascular inflammatory response of atherosclerosis. Cardiovascular research, 86 (2), 192–201.
  • Zhang, H., and Zhang, C., 2010. Adipose “talks” to distant organs to regulate insulin sensitivity and vascular function. Obesity ( Obesity), 18 (11), 2071–2076.
  • Zhang, W., et al., 2011. Inflammation and diabetic retinal microvascular complications. Journal of cardiovascular disease research, 2 (2), 96–103.
  • Zhou, R., et al., 2010. Thioredoxin-interacting protein links oxidative stress to inflammasome activation. Nature immunology, 11 (2), 136–140.
  • Zhu, Y., et al., 2016. Overexpression of miR-29b reduces collagen biosynthesis by inhibiting heat shock protein 47 during skin wound healing. Translational research, 178, 38.e36–53.e36.
  • Ziegler, D., et al., 2004. Oxidative stress and antioxidant defense in relation to the severity of diabetic polyneuropathy and cardiovascular autonomic neuropathy. Diabetes care, 27 (9), 2178–2183.
  • Zilliox, L., and Russell, J.W., 2011. Treatment of diabetic sensory polyneuropathy. Current treatment options in neurology, 13 (2), 143–159.
  • Zinman, B., et al., 1999. Circulating tumor necrosis factor-alpha concentrations in a native Canadian population with high rates of type 2 diabetes mellitus. The journal of clinical endocrinology & metabolism, 84 (1), 272–278.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.